Future work should include external validation, prospective and interventional studies, and mechanistic investigations (inflammation, redox, lipid pathways, and socioeconomic context) to clarify whether and to what extent modifying anthocyanidin intake can influence CKM–depression outcomes. Here, CKM is linked to depressive symptom measurement.